Follow
natalya vasilevich
natalya vasilevich
group leader ASINEX Ltd.
Verified email at asinex.com
Title
Cited by
Cited by
Year
Synthesis and antiamnesic activity of a series of N-acylprolyl-containing dipeptides
TA Gudasheva, TA Voronina, RU Ostrovskaya, GG Rozantsev, ...
European journal of medicinal chemistry 31 (2), 151-157, 1996
1511996
Examination of the 1, 4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design
L Sun, NI Vasilevich, JA Fuselier, SJ Hocart, DH Coy
Bioorganic & medicinal chemistry letters 14 (9), 2041-2046, 2004
882004
Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors
DO Koltun, EQ Parkhill, NI Vasilevich, AI Glushkov, TM Zilbershtein, ...
Bioorganic & medicinal chemistry letters 19 (7), 2048-2052, 2009
672009
Lessons from Natural Products Chemistry Can Offer Novel Approaches for Synthetic Chemistry in Drug Discovery: Miniperspective
NI Vasilevich, RV Kombarov, DV Genis, MA Kirpichenok
Journal of Medicinal Chemistry 55 (16), 7003-7009, 2012
612012
An adjustable release rate linking strategy for cytotoxin–peptide conjugates
JA Fuselier, L Sun, SN Woltering, WA Murphy, N Vasilevich, DH Coy
Bioorganic & medicinal chemistry letters 13 (5), 799-803, 2003
502003
3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
D Koltun, E Parkhill, M Boze, J Zablocki, N Vasilevich, E Mayboroda, ...
US Patent App. 12/252,057, 2009
482009
3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
D Koltun, E Parkhill, M Boze, J Zablocki, N Vasilevich, E Mayboroda, ...
US Patent App. 12/100,399, 2008
482008
Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors
DO Koltun, NI Vasilevich, EQ Parkhill, AI Glushkov, TM Zilbershtein, ...
Bioorganic & medicinal chemistry letters 19 (11), 3050-3053, 2009
452009
Mild and Direct C–H Arylation of Quinoxalin-2 (1H)-ones with Aryldiazonium Salts under Metal-Free Conditions
K Yin, R Zhang
Synlett 29 (05), 597-602, 2018
442018
Potent, orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors
DO Koltun, TM Zilbershtein, VA Migulin, NI Vasilevich, EQ Parkhill, ...
Bioorganic & medicinal chemistry letters 19 (15), 4070-4074, 2009
332009
Abilities of 3, 4-diarylfuran-2-one analogs of combretastatin A-4 to inhibit both proliferation of tumor cell lines and growth of relevant tumors in nude mice
L Sun, NI Vasilevich, JA Fuselier, DH Coy
Anticancer research 24 (1), 179-186, 2004
232004
Pteridinone derivatives for use as stearoyl CoA desaturase inhibitors
J Chisholm, D Koltun, J Zablocki, E Parkhill, A Glushkov, N Vasilevich, ...
US Patent 7,662,819, 2010
202010
Pyridol [2, 3-B] pyrazinones for use as stearoyl CoA desaturase inhibitors
D Koltun, J Zablocki, E Parkhill, A Glushkov, N Vasilevich, T Zilbershtein, ...
US Patent 7,893,066, 2011
19*2011
Efficient synthesis of 5-substituted 2-aryl-6-cyanoindolizines via nucleophilic substitution reactions
EV Babaev, NI Vasilevich, AS Ivushkina
Beilstein Journal of Organic Chemistry 1 (1), 9, 2005
182005
Synthesis and nootropic activity of pyrrolidino [1, 2-a] diazacycloalkanes
TA Gudasheva, NI Vasilevich, RU Ostrovskaya, SS Trofimov, TA Voronina, ...
Pharmaceutical chemistry journal 30, 562-567, 1996
161996
Selective conversion of O-succinimidyl carbamates to N-(O-carbamoyl)-succinmonoamides and ureas
NI Vasilevich, ND Sachinvala, K Maskos, DH Coy
Tetrahedron Letters 43 (18), 3443-3445, 2002
15*2002
Search for Potent and Selective Aurora A Inhibitors Based on General Ser/Thr Kinase Pharmacophore Model
NI Vasilevich, VV Tatarskiy, EA Aksenova, ...
Pharmaceuticals 9 (2), 19, 2016
132016
2H-BENZO [b][1, 4] OXAZIN-3 (4H)-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
D Koltun, J Zablocki, N Vasilevich, V Migulin
US Patent App. 12/417,854, 2009
122009
Propenylamide and propenylsulfonamide cephalosporins as a novel class of anti-MRSA β-lactams
J Pohlmann, NI Vasilevich, AI Glushkov, L Kellenberger, S Shapiro, ...
Bioorganic & medicinal chemistry letters 20 (15), 4635-4638, 2010
112010
General Ser/Thr Kinases Pharmacophore Approach For Selective Kinase Inhibitors Search As Exemplified By Design Of Potent And Selective Aurora A Inhibitors
NI Vasilevich, EA Aksenova, DN Kazyulkin, II Afanasyev
Chem.Biology & Drug Design, 2016
92016
The system can't perform the operation now. Try again later.
Articles 1–20